The name is the button.

An agent writes the code now, and a human thumb hovers over Accept all a hundred times a day. The honest question of this decade is what, exactly, you just accepted. So I read the diff.

Eight years as a backend engineer in Stockholm, back in Tokyo since 2023, and I still ship something small most nights, usually badly. My one rule: the only real review of a model is the thing you built with it. That is why there is no leaderboard on this site.

Around a hundred and forty sources come through — the labs' own posts, the papers, the tools, the runtimes and languages nobody is watching yet, the chip under the demo, and the newsletters people actually forward. What is moving gets counted so the week reads at a glance, and every few days I explain one mechanism in plain words.

A story here is a headline, a short excerpt, one image and the link to whoever wrote it. We never reproduce the post; the images belong to their authors. A post written in Japanese appears in Japanese, exactly as it was published, and the link goes to the original.

— Yuki Halvorsen, Tokyo

← Accept All Archive

OpenAI NewsLabs

OpenAI acquires Orchestra Bio

10.20

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

Funding & deals

Read at OpenAI News ↗

One letter a week, starting soon.

Latest

OpenAI acquires Orchestra Bio

Related

ValleyNscale and Anthropic are reportedly in talks for yet another $45B compute deal TechCrunch AI

ValleyNvidia, Dell back $200M round for AI model developer doubleAI SiliconANGLE

ValleyElon Musk, Anthropic pledge to give away billions of dollars in shares SiliconANGLE

VoicesNew paper: Emerging trends in AI agent evaluation AI Snake Oil

SiliconVideo Interview: Applied Materials CEO on the Economics Behind Its $5B EPIC Bet EE Times

ValleyTolan snags $30M for its AI companion that helps users navigate life TechCrunch AI